Last updated: 2026-09-16 11:44:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Polyrizon Ltd. (PLRZ) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $11.32, with a market capitalisation of $26.85M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.88 to $18.20. This page covers its latest market performance, valuation, price trends and company information.
$26.85M | |
$11.10 | |
$7,200.00 | |
$2.88 | |
$11.32 | |
995.00 | |
67.14K | |
-- | |
$18.20 | |
$2.88 | |
-- | |
-- |
Polyrizon Ltd. (PLRZ) is trading at $11.29 in pre-market trading as of 2026-09-15 23:31:00, down 0.27% ($0.03) from the previous close of $11.32
Pre-market trading shows how investors are pricing PLRZ before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Over the past seven days, Polyrizon Ltd. (PLRZ) moved from $11.24 to $11.32, representing a gain of 0.70% ($0.08).
The stock traded between $10.32 and $12.72 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 81.82 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 55.1%
PLRZ is currently trading at $11.32, placing it 55.1% of the way from its 52-week low of $2.88 to its 52-week high of $18.20. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. The company's technology platforms are Capture & Contain and Trap & Target.
| Employees | 1 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Polyrizon Ltd. (PLRZ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.